Cross-Sector entity
All 1 tracked stories fall under one category: pharma. Bayer is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Glyphosate appears in 1 tracked Cross-Sector story from February 18, 2026.
1 verified story tracked
Last mentioned: Feb 18, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Bayer is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Glyphosate appears in 1 tracked Cross-Sector story from February 18, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Glyphosate. Shared-story counts are live from our verified record — not editorial picks.
End of Certainty Period
The 21-year structured resolution period is slated to conclude.
$7.25B Settlement Announced
Bayer agrees to a new $7.25 billion deal with a 21-year certainty plan.
Initial $10B Settlement
Bayer announces a massive settlement to resolve current claims, but future liability remains.
Monsanto Acquisition
Bayer completes $63 billion acquisition of Monsanto, inheriting Roundup litigation.
Bayer has reached a $7.25 billion settlement agreement to resolve long-standing litigation surrounding its Roundup herbicide. The deal includes a 21-year framework designed to provide legal and financial certainty for the company following years of costly courtroom battles.
